Establishment Labs Holdings Inc Quick Ratio (ESTA) starting from the third quarter 2026 to third quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Establishment Labs Holdings Inc   (NASDAQ: ESTA)

Establishment Labs Holdings Inc 's Quick Ratio

ESTA's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2026, Quick Ratio fell to 1.06 below Establishment Labs Holdings Inc average.

Within Medical Equipment & Supplies industry 105 other companies have achieved higher Quick Ratio than Establishment Labs Holdings Inc in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 2199, from total ranking in the second quarter 2026 at 2582.

Explain Quick Ratio?
How much Cash & cash equivalents ESTA´s has?
What are ESTA´s Current Liabilities?




API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/ESTA/financial-strength
https://api.csimarket.com/api/v1/companies/ESTA/fundamentals
https://api.csimarket.com/api/v1/companies/ESTA/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
ESTA Quick Ratio (Sep 30 2026)
Q3
(Jun 30 2026)
Q2
(Mar 31 2026)
Q1
(Dec 31 2025)
Q4
(Sep 30 2025)
Q3
Y / Y Current Liabilities Change -0.51 %
Y / Y Cash & cash equivalent Change 7.35 %
Quick Ratio MRQ 1.06
ESTA's Total Ranking # 2199
Seq. Current Liabilities Change 10.93 %
Seq. Cash & cash equivalent Change 6.54 %



Quick Ratio third quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 106
Healthcare Sector # 616
Overall Market # 1927


Quick Ratio Statistics
High Average Low
5.62 1.86 0.68
(Sep 30 2018)   (Jun 30 2025)




Financial Statements
Establishment Labs Holdings Inc 's Current Liabilities $ 72 Millions Visit ESTA's Balance sheet
Establishment Labs Holdings Inc 's Cash & cash equivalent $ 76 Millions Visit ESTA's Balance sheet
Source of ESTA's Sales Visit ESTA's Sales by Geography


Cumulative Establishment Labs Holdings Inc 's Quick Ratio

ESTA's Quick Ratio for the trailling 12 Months

ESTA Quick Ratio

(Sep 30 2026)
12 Months
(Jun 30 2026)
12 Months
(Mar 31 2026)
12 Months
(Dec 31 2025)
12 Months
(Sep 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth 3.94 %
Y / Y Cash & cash equivalent TTM Growth 2.06 %
Quick Ratio TTM 0.96
Total Ranking TTM # 3968
Seq. Current Liabilities TTM Growth -0.12 %
Seq. Cash & cash equivalent TTM Growth 1.82 %


On the trailing twelve months basis ESTA Cash & cash equivalent improved by 7.35 % in Q3 2026 year on year, while Current Liabilities increased to $72 millions, this led to increase in in Establishment Labs Holdings Inc 's Quick Ratio to 0.96, Quick Ratio remained below ESTA average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Establishment Labs Holdings Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 3010 to 3968.

Explain Quick Ratio?
How much Cash & cash equivalents ESTA´s has?
What are ESTA´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 202
Healthcare Sector # 895
Within the Market # 3968


trailing twelve months Quick Ratio Statistics
High Average Low
3.88 1.83 0.85
(Dec 31 2020)   (Mar 31 2026)




Companies with similar Quick Ratio in the quarter ending Sep 30 2026, within Medical Equipment & Supplies Industry Quick RatioSep 30 2026 MRQ Cash & cash equivalentSep 30 2026 MRQ Current Liabilities
Sharps Technology Inc   2.82 $ 7.478  Millions$ 2.650  Millions
Edwards Lifesciences Corporation  2.81 $ 4,683.700  Millions$ 1,664.300  Millions
Mimedx Group Inc   2.81 $ 120.791  Millions$ 43.031  Millions
Pulse Biosciences Inc   2.74 $ 36.725  Millions$ 13.395  Millions
Staar Surgical Co  2.73 $ 206.414  Millions$ 75.541  Millions
Medinotec Inc   2.68 $ 2.584  Millions$ 0.963  Millions
Glaukos Corp  2.66 $ 337.478  Millions$ 126.726  Millions
Pulmonx Corporation  2.57 $ 53.245  Millions$ 20.739  Millions
Beta Bionics Inc   2.48 $ 81.551  Millions$ 32.836  Millions
Irhythm Holdings Inc   2.46 $ 560.719  Millions$ 228.025  Millions
Genedx Holdings Corp   2.38 $ 170.118  Millions$ 71.403  Millions
Apyx Medical Corp  2.37 $ 25.777  Millions$ 10.870  Millions
Atricure Inc   2.23 $ 187.031  Millions$ 83.972  Millions
Electromed Inc   2.19 $ 15.875  Millions$ 7.261  Millions
Inspire Medical Systems inc   1.96 $ 190.803  Millions$ 97.438  Millions
Merit Medical Systems Inc  1.90 $ 503.551  Millions$ 265.083  Millions
Nephros Inc   1.89 $ 4.546  Millions$ 2.409  Millions
Warby Parker Inc   1.77 $ 287.914  Millions$ 162.226  Millions
Anika Therapeutics Inc   1.68 $ 44.957  Millions$ 26.725  Millions
EBR Systems, Inc.  1.63 $ 85.415  Millions$ 52.539  Millions
Intuitive Surgical Inc   1.60 $ 4,042.500  Millions$ 2,533.000  Millions
Tactile Systems Technology Inc   1.58 $ 75.110  Millions$ 47.499  Millions
Edap Tms Sa  1.56 $ 56.269  Millions$ 36.070  Millions
Neuraxis Inc   1.55 $ 4.477  Millions$ 2.888  Millions
Envista Holdings Corporation  1.42 $ 1,158.800  Millions$ 816.300  Millions
Inogen Inc   1.38 $ 96.840  Millions$ 70.265  Millions
Intelligent Bio Solutions Inc   1.30 $ 5.930  Millions$ 4.578  Millions
Si bone inc   1.20 $ 35.460  Millions$ 29.619  Millions
Medline Inc   1.12 $ 3,608.000  Millions$ 3,211.000  Millions
Pro dex Inc   1.10 $ 14.219  Millions$ 12.884  Millions

Date modified: 2026-11-07T13:23:11+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.